about
Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.Charged liposomes as carriers to enhance the permeation through the skin.Bimodal release of olanzapine from lipid microspheres.New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.Alginate/chitosan particulate systems for sodium diclofenac release.Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers.Eudragit RS-PM and Ethocel 100 Premium: influence over the behavior of didanosine inert matrix system.In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery.Release of indomethacin from ultrasound dry granules containing lactose-based excipients.Modified doxorubicin for improved encapsulation in PVA polymeric micelles.Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13.Development and validation of a reverse-phase liquid chromatographic method for the assay of lidocaine hydrochloride in alginate-Gantrez microspheres.Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems.The role of the drug/excipient particle size ratio in the percolation model for tablets.Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.Robust optimization of alginate-Carbopol 940 bead formulations.A rapid HPLC method for the quantification of tyrothricin, menthol, and benzocaine in pharmaceutical formulations.Diclofenac salts, part 6: release from lipid microspheresFractal analysis of sodium cholate particlesDissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycolsThe application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamtereneImprovement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrinEvaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodiumValidation study of the conductometrical analysis. Application to the drug release studies from controlled release systemsDesign of controlled release inert matrices of naltrexone hydrochloride based on percolation conceptsApplying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin deliveryDevelopment and validation of a high performance chromatographic method for determining sumatriptan in niosomes
P50
Q30583582-CFD759F4-F532-43AF-8584-077606B92B35Q33215175-E2DF4892-88EC-4C86-ADE8-EDDB044424EAQ33216629-9FCEEC5A-60C1-4668-AD5B-098C563D60FCQ33233567-AB60FBF8-604C-4BB2-B91A-F5E044294326Q37873946-ABC92CBD-CF58-4A58-854D-93E54153EEE7Q42926550-063D6374-65D8-4A2E-B161-7D9CB0A27F2DQ42994855-873502AA-2F58-4B86-AE45-28FEC27DB6A9Q43854190-8A2ABB30-85A0-4B5C-B48D-495D3A23F295Q43882282-F48AC4AA-2780-4903-83C4-C8C9890AD58EQ44165755-90E4FEDD-AE2D-4DED-BE07-56B95BD7195EQ44588003-3AEDA015-D480-4D98-8C21-258070C5F5C6Q45226192-2434DC2C-6F41-4B54-B193-861B7E6A2775Q46413846-2BE70EFC-B8C7-4101-A21B-59D269CD0EA2Q46451970-36C6B368-988E-42FD-9AF0-E200D3707DBDQ46690469-CFCB4172-45FB-4221-8442-9A83257042E9Q47270113-55D958E0-6885-495A-8115-F91A77948B3BQ47292757-40688C15-4807-491C-B9A5-A78009D55BD6Q48615307-4E77808C-FBA8-4E0D-B9DA-BF3358E737EFQ51362305-BD0E28F8-F606-4A88-AC4E-E075930F02ACQ51628011-700B2EE8-AF8A-42D6-B91D-ECBE9C4FCAE8Q56985017-783151DA-6D8A-47D8-93CA-3478FF3D94FEQ71699403-81C1E232-F7CE-4E6A-92AD-9ADD24049E6DQ71785036-9C77F8A3-CA65-4A1D-A704-D0D94DB71A99Q72148718-8E06C640-E11C-4168-A87D-A512A2B317D0Q72209681-FB5E8364-A967-4CA3-BD2B-F34EC91F16FBQ72994589-81163070-05E8-4F53-BE1D-189FF917FB16Q74581396-C5823216-4A7A-4A6B-9E7E-3E3B007E6DC9Q77720004-F234833C-C478-4A6F-9EBA-E193B58F844CQ77886055-A57C4B37-2D8E-44B6-8D36-2959933FC8B8Q84582373-83D31A2E-94AC-4BCF-A196-7BA42EC79B08Q87439164-C4E18406-A8CB-4E80-AD75-2886972D851E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio M. Rabasco
@ast
Antonio M. Rabasco
@en
Antonio M. Rabasco
@es
Antonio M. Rabasco
@nl
Antonio M. Rabasco
@sl
type
label
Antonio M. Rabasco
@ast
Antonio M. Rabasco
@en
Antonio M. Rabasco
@es
Antonio M. Rabasco
@nl
Antonio M. Rabasco
@sl
prefLabel
Antonio M. Rabasco
@ast
Antonio M. Rabasco
@en
Antonio M. Rabasco
@es
Antonio M. Rabasco
@nl
Antonio M. Rabasco
@sl
P106
P1153
35577553800
P21
P31
P496
0000-0002-8861-6090
P569
2000-01-01T00:00:00Z